Good morning gentlemen.
So perhaps the spoke can be good for something.
I was reading more about ASFX. It seems bill SB486, the one that makes the needle destruction device mandatory in California, is set to be made law at 11:59pm this coming Sunday.
This can happen two ways: first, Governator can sign it, in which case it becomes law immediately. Or, he can not sign it, it will become law 11:59 on Sunday.
Which means the only way it wont become law is if he actively Vetoes the bill. Those are pretty good odds in our favor I think.
Does this process sound correct to you guys? It sounds like a logical process to me.
Last edited by ShotsII; 10-07-2009 at 10:43 AM.
LFBG certainly is rockin today. It made it up to 9 cents a short time ago and is heading back down now.
SIRI got down to below 52 cents this morning. That is a 15% discount over last week. It may be time to consider getting in there, if even for day trading.
CBAI
This is very positive news. I own this company and we've been talking about it for awhile. It may be a bit of a long term buy, but I think it might be worth setting a few hundred dollars into.
Cord Blood America Announces Debt Reduction Tally: $8.7 Million in 2009; $3.7 Million in Third Quarter
Wednesday 10/07/2009 5:00 AM ET - Pr Newswire
Related Companies
Symbol Last %Chg
CBAI 0.0093 8.14%
As of 10:43 AM ET 10/7/09
Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has reduced its debt by a total of $3.7 million in the third quarter of 2009. Total debt eliminated in 2009 is $8.7 million.
"We recently announced the retirements of four separate notes and wanted to give our investors a concise tally for the quarter. We have emphasized to our investors throughout the year that debt reduction is one of the pillars needed for our ongoing and future success. We are pleased that we have been able to consistently announce debt reductions in 2009. We urge our shareholders to continue to follow our progress as we strengthen the Company and its balance sheet for the long term," said Matthew Schissler, co-founder and CEO.
Cord Blood America also announced this year that it retired $2.53 million of long-term debt with an opportunity fund and that it received a $2.3 million commitment to finance its stem cell laboratory and headquarters in Las Vegas
Whoa! ARYC up to .49 (22.5%) on only 18500 shares.